SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
16-Jul-24 4:31 PM View: | Valauri Christina Rizopoulos Director | Transgenomic Inc. (PRPO) | 15-Jul-24 | Grant | 2,103 | $4.63 | $9,736.89 | 145% 1.45K to 3.55K | |
16-Jul-24 4:30 PM View: | Cohen David Seth Director | Transgenomic Inc. (PRPO) | 15-Jul-24 | Grant | 2,832 | $4.63 | $13,112.20 | 7% 42.75K to 45.58K | |
16-Jul-24 4:30 PM View: | Andrews Ronald Asbury Director | Transgenomic Inc. (PRPO) | 15-Jul-24 | Grant | 2,157 | $4.63 | $9,986.91 | 29% 7.46K to 9.62K | |
17-Apr-24 4:21 PM View: | Cohen David Seth Director | Transgenomic Inc. (PRPO) | 15-Apr-24 | Grant | 3,575 | $6.67 | $23,845.20 | 9% 39.17K to 42.75K | |
17-Apr-24 4:21 PM View: | Andrews Ronald Asbury Director | Transgenomic Inc. (PRPO) | 15-Apr-24 | Grant | 3,153 | $6.66 | $20,999.00 | 73% 4.31K to 7.46K | |
17-Apr-24 4:26 PM View: | Laporte Kathleen Director | Transgenomic Inc. (PRPO) | 15-Apr-24 | Grant | 9,693 | $6.70 | $64,943.10 | 2564% 0.38K to 10.07K | |
17-Apr-24 4:24 PM View: | Cossman Jeffrey Director | Transgenomic Inc. (PRPO) | 15-Apr-24 | Grant | 8,143 | $6.70 | $54,558.10 | 2561% 0.32K to 8.46K | |
17-Apr-24 4:20 PM View: | Valauri Christina Rizopoulos Director | Transgenomic Inc. (PRPO) | 15-Apr-24 | Grant | 1,446 | $6.74 | $9,746.04 | 100% 0 to 1.45K | |
17-Apr-24 4:25 PM View: | Sandberg Richard A Director | Transgenomic Inc. (PRPO) | 15-Apr-24 | Grant | 5,913 | $6.66 | $39,380.60 | 58% 10.12K to 16.03K | |
31-Oct-23 4:30 PM View: | Fisher Douglas Director | Transgenomic Inc. (PRPO) | 27-Oct-23 | Grant | 5,174 | -- | -- | 1300% 0.4K to 5.57K | |
26-Oct-23 4:30 PM View: | Andrews Ronald Asbury Director | Transgenomic Inc. (PRPO) | 24-Oct-23 | Grant | 4,005 | -- | -- | 1322% 0.3K to 4.31K | |
26-Oct-23 4:30 PM View: | Cohen David Seth Director | Transgenomic Inc. (PRPO) | 24-Oct-23 | Grant | 3,905 | -- | -- | 11% 35.27K to 39.17K | |
26-Oct-23 4:30 PM View: | Sandberg Richard A Director | Transgenomic Inc. (PRPO) | 24-Oct-23 | Grant | 7,510 | -- | -- | 288% 2.61K to 10.12K | |
14-Sep-23 4:41 PM View: | Laporte Kathleen Director | Transgenomic Inc. (PRPO) | 12-Sep-23 | Grant | 7,575 | -- | -- | 100% 0 to 7.58K | |
14-Sep-23 4:40 PM View: | Cossman Jeffrey Director | Transgenomic Inc. (PRPO) | 12-Sep-23 | Grant | 6,363 | -- | -- | 100% 0 to 6.36K | |
14-Sep-23 4:40 PM View: | Cohen David Seth Director | Transgenomic Inc. (PRPO) | 12-Sep-23 | Grant | 5,909 | -- | -- | < 1% 699.43K to 705.34K | |
14-Sep-23 4:41 PM View: | Sandberg Richard A Director | Transgenomic Inc. (PRPO) | 12-Sep-23 | Grant | 11,363 | -- | -- | 28% 40.85K to 52.21K | |
14-Sep-23 4:39 PM View: | Andrews Ronald Asbury Director | Transgenomic Inc. (PRPO) | 12-Sep-23 | Grant | 6,060 | -- | -- | 100% 0 to 6.06K | |
14-Sep-23 4:40 PM View: | Fisher Douglas Director | Transgenomic Inc. (PRPO) | 12-Sep-23 | Grant | 7,954 | -- | -- | 100% 0 to 7.95K | |
23-Jan-23 6:34 PM View: | Sandberg Richard A Director | Transgenomic Inc. (PRPO) | 20-Jan-23 | Private Purchase | 20,000 | $0.78 | $15,530.00 | 96% 20.85K to 40.85K | |
03-Jan-23 5:09 PM View: | Danieli Ilan Chief Executive Officer Director | Transgenomic Inc. (PRPO) | 03-Jan-23 | Private Purchase | 16,500 | $0.60 | $9,857.10 | 41% 40.55K to 57.05K | |
03-Jan-23 5:10 PM View: | Sabet Ahmed Zaki Chief Operating Officer | Transgenomic Inc. (PRPO) | 03-Jan-23 | Private Purchase | 750 | $0.60 | $448.05 | 12% 6.11K to 6.86K | |
20-Dec-22 4:01 PM View: | Sandberg Richard A Director | Transgenomic Inc. (PRPO) | 20-Dec-22 | Private Purchase | 20,000 | $0.55 | $11,050.00 | 2364% 0.85K to 20.85K | |
06-Oct-22 2:17 PM View: | Danieli Ilan Chief Executive Officer Director | Transgenomic Inc. (PRPO) | 03-Oct-22 | Private Purchase | 11,000 | $0.87 | $9,570.00 | 37% 29.55K to 40.55K | |
06-Oct-22 2:20 PM View: | Sabet Ahmed Zaki Chief Operating Officer | Transgenomic Inc. (PRPO) | 03-Oct-22 | Private Purchase | 500 | $0.87 | $435.00 | 9% 5.61K to 6.11K | |
01-Mar-22 6:24 PM View: | Sabet Ahmed Zaki Chief Operating Officer | Transgenomic Inc. (PRPO) | 01-Mar-22 | Market Purchase | 327 | $1.54 | $504.66 | 6% 5.29K to 5.61K | (< 1%) |
01-Mar-22 6:19 PM View: | Danieli Ilan Chief Executive Officer Director | Transgenomic Inc. (PRPO) | 01-Mar-22 | Market Purchase | 3,268 | $1.55 | $5,060.50 | 12% 26.28K to 29.55K | (< 1%) |
10-Dec-21 4:56 PM View: | Danieli Ilan Chief Executive Officer Director | Transgenomic Inc. (PRPO) | 01-Dec-21 | Market Purchase | 2,577 | $1.89 | $4,870.53 | 11% 23.7K to 26.28K | (2%) |
10-Dec-21 4:57 PM View: | Sabet Ahmed Zaki Chief Operating Officer | Transgenomic Inc. (PRPO) | 01-Dec-21 | Market Purchase | 258 | $1.89 | $487.62 | 5% 5.03K to 5.29K | (2%) |
08-Sep-21 5:11 PM View: | Danieli Ilan Chief Executive Officer Director | Transgenomic Inc. (PRPO) | 07-Sep-21 | Market Purchase | 1,484 | $3.36 | $4,981.05 | 7% 22.22K to 23.7K | (4%) |
08-Sep-21 5:10 PM View: | Sabet Ahmed Zaki Chief Operating Officer | Transgenomic Inc. (PRPO) | 07-Sep-21 | Market Purchase | 149 | $3.36 | $499.89 | 3% 4.88K to 5.03K | (4%) |
03-Aug-21 1:09 PM View: | Cohen David Seth Director | Transgenomic Inc. (PRPO) | 10-Jun-21 | Market Sale | 69,962 | $3.99 | $279,148.00 | (9%) 820.7K to 750.74K | 23% |
02-Jun-21 5:00 PM View: | Danieli Ilan Chief Executive Officer Director | Transgenomic Inc. (PRPO) | 01-Jun-21 | Market Purchase | 755 | $3.37 | $2,545.33 | 4% 21.46K to 22.22K | 5% |
02-Jun-21 5:01 PM View: | Sabet Ahmed Zaki Chief Operating Officer | Transgenomic Inc. (PRPO) | 01-Jun-21 | Market Purchase | 151 | $3.37 | $508.72 | 3% 4.73K to 4.88K | 5% |
03-Aug-21 1:07 PM View: | Cohen David Seth Director | Transgenomic Inc. (PRPO) | 27-May-21 | Private Sale | 40,178 | $3.99 | $160,310.00 | (5%) 860.88K to 820.7K | |
03-Mar-21 5:20 PM View: | Danieli Ilan Chief Executive Officer Director | Transgenomic Inc. (PRPO) | 01-Mar-21 | Market Purchase | 1,025 | $2.46 | $2,521.50 | 5% 20.44K to 21.46K | 2% |
03-Dec-20 4:31 PM View: | Danieli Ilan Chief Executive Officer Director | Transgenomic Inc. (PRPO) | 01-Dec-20 | Market Purchase | 1,111 | $2.23 | $2,477.53 | 6% 19.33K to 20.44K | (7%) |
03-Dec-20 4:31 PM View: | Sabet Ahmed Zaki Chief Operating Officer | Transgenomic Inc. (PRPO) | 01-Dec-20 | Market Purchase | 222 | $2.23 | $495.06 | 5% 4.51K to 4.73K | (7%) |
03-Sep-20 9:10 PM View: | Sabet Ahmed Zaki Chief Operating Officer | Transgenomic Inc. (PRPO) | 01-Sep-20 | Market Purchase | 130 | $2.16 | $281.23 | 3% 4.38K to 4.51K | (4%) |
03-Sep-20 9:09 PM View: | Danieli Ilan Chief Executive Officer Director | Transgenomic Inc. (PRPO) | 01-Sep-20 | Market Purchase | 1,150 | $2.14 | $2,466.75 | 6% 18.18K to 19.33K | (3%) |
14-Jul-20 4:16 PM View: | Sabet Ahmed Zaki Chief Operations Officer | Transgenomic Inc. (PRPO) | 07-Jul-20 | Purchase | 169 | $1.60 | $270.40 | 4% 4.21K to 4.38K | |
14-Jul-20 4:15 PM View: | Sabet Ahmed Zaki Chief Operations Officer | Transgenomic Inc. (PRPO) | 07-Jul-20 | Private Purchase | 281 | $0.96 | $269.76 | 7% 3.93K to 4.21K | |
07-Jul-20 4:30 PM View: | Danieli Ilan Chief Executive Officer Director | Transgenomic Inc. (PRPO) | 06-Jul-20 | Purchase | 1,550 | $1.60 | $2,480.00 | 11% 14.04K to 15.59K | |
07-Jul-20 4:31 PM View: | Danieli Ilan Chief Executive Officer Director | Transgenomic Inc. (PRPO) | 06-Jul-20 | Private Purchase | 2,585 | $0.96 | $2,481.60 | 17% 15.59K to 18.18K | |
02-Dec-19 4:30 PM View: | Danieli Ilan Chief Executive Officer Director | Transgenomic Inc. (PRPO) | 02-Dec-19 | Market Purchase | 1,176 | $2.09 | $2,463.13 | 9% 12.87K to 14.04K | (2%) |
05-Sep-19 4:32 PM View: | Danieli Ilan Chief Executive Officer Director | Transgenomic Inc. (PRPO) | 03-Sep-19 | Market Purchase | 965 | $2.58 | $2,489.70 | 8% 11.9K to 12.87K | (20%) |
10-Jun-19 4:09 PM View: | Danieli Ilan Chief Executive Officer Director | Transgenomic Inc. (PRPO) | 07-Jun-19 | Market Purchase | 586 | $4.22 | $2,474.68 | 100% 0 to 0.59K | (51%) |
30-Aug-18 5:48 PM View: | Kirk Randal J 10% Owner | Transgenomic Inc. (PRPO) | 28-Aug-18 | Market Sale | 24,600 | $0.41 | $10,086.00 | (2%) 1.36M to 1.33M | 63% |
13-Oct-17 4:31 PM View: | Rimer Mark Director 10% Owner | Transgenomic Inc. (PRPO) | 10-Oct-17 | Disposition (other) | 124,496 | -- | -- | (100%) 124.5K to 0 | |
15-Sep-17 4:30 PM View: | Rimer Mark Director 10% Owner | Transgenomic Inc. (PRPO) | 08-Sep-17 | Conversion | 209,972 | -- | -- | 22% 942.31K to 1.15M |